Desoxypyridoxine has been tested in human leukaemia but no evidence that it produces any material benefit has been recorded. Apart from possible antimetabolites, and more specifically, substances which may interfere with nucleoprotein metabolism, compounds related in chemical structure to the few compounds already known to affect the leukasmic process, e.g. the nitrogen mustards, carbamates, etc., form a basis for testing for anti-leukaemic activity.
In the search for new chemotherapeutic agents for acute leukaemia it seems probable at the present day that the main attention will be focused on the synthesis of nucleic acid. It is, however, also desirable that an understanding of the mode of action of cortisone and ACTH, and a knowledge of the mechanism of resistance of the leukaemic cell to these hormones and the folic acid antagonists be obtained. Although much work remains to be carried out, the important developments in the chemotherapy of acute leukaemia in the past few years suggest that further advances may be looked forward to with optimism. 
